Calculating drug needs and costs for treating visceral leishmaniasis using local patient anthropometric data from Brazil, East Africa and Indian subcontinent.
Abstract
Data on the age, sex, weight, and height of visceral leishmaniasis patients in different endemic regions of the world were collected, and used to forecast the costs and volumes of drug therapy. It was found that there were significant differences between patient populations in anthropometric variables, and therefore in treatment costs; analysis of these differences can promote cost-saving and effective use of available therapies involving different treatment and control strategies in different populations.
Citation
Presentation from American Society of Tropical Medicine and Hygiene 58th Annual Meeting, Washington, DC, USA, 18-22 November 2009.
Links
Updates to this page
Published 1 January 2009